Finally, Protagonist Therapeutics (NASDAQ:PTGX) has indicated that its financial runway extends beyond the fourth quarter of 2028, providing the company with a stable foundation to continue its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback